Wnt-related molecules and signaling pathway equilibrium in hematopoiesis
- PMID: 19128790
- PMCID: PMC2975490
- DOI: 10.1016/j.stem.2008.12.004
Wnt-related molecules and signaling pathway equilibrium in hematopoiesis
Abstract
There is near consensus that Wnt family molecules establish important gradients within niches where hematopoietic stem cells (HSC) reside. We review recent papers suggesting that a delicate balance is required between competing Wnt ligands and corresponding signaling pathways to maintain HSC integrity. Some steps in the transitions from HSC to lymphoid progenitor seem to be partially reversible and under the influence of Wnts. In addition, it has been recently suggested that HSC can oscillate between dormant versus active or lineage-biased states. We speculate that Wnts control a reflux process that may sustain stem cell self-renewal and differentiation potential.
Figures
Similar articles
-
Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development.Leukemia. 2012 Mar;26(3):414-21. doi: 10.1038/leu.2011.387. Epub 2011 Dec 15. Leukemia. 2012. PMID: 22173215 Free PMC article. Review.
-
Regulation of hematopoiesis and the hematopoietic stem cell niche by Wnt signaling pathways.Cell Res. 2007 Sep;17(9):746-58. doi: 10.1038/cr.2007.69. Cell Res. 2007. PMID: 17768401 Review.
-
Wnt signaling in hematopoiesis: crucial factors for self-renewal, proliferation, and cell fate decisions.J Cell Biochem. 2010 Apr 1;109(5):844-9. doi: 10.1002/jcb.22467. J Cell Biochem. 2010. PMID: 20069555 Review.
-
Lrp5 and Lrp6 are required for maintaining self-renewal and differentiation of hematopoietic stem cells.FASEB J. 2019 Apr;33(4):5615-5625. doi: 10.1096/fj.201802072R. Epub 2019 Jan 22. FASEB J. 2019. PMID: 30668923 Free PMC article.
-
Wnt-5A/B Signaling in Hematopoiesis throughout Life.Cells. 2020 Jul 29;9(8):1801. doi: 10.3390/cells9081801. Cells. 2020. PMID: 32751131 Free PMC article. Review.
Cited by
-
The hedgehog pathway in hematopoiesis and hematological malignancy.Front Oncol. 2022 Aug 25;12:960943. doi: 10.3389/fonc.2022.960943. eCollection 2022. Front Oncol. 2022. PMID: 36091167 Free PMC article. Review.
-
Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche.Ann Hematol. 2024 Dec;103(12):5035-5057. doi: 10.1007/s00277-024-05773-1. Epub 2024 Apr 30. Ann Hematol. 2024. PMID: 38684510 Review.
-
WNT Signaling in Hematological Malignancies.Front Oncol. 2020 Dec 21;10:615190. doi: 10.3389/fonc.2020.615190. eCollection 2020. Front Oncol. 2020. PMID: 33409156 Free PMC article. Review.
-
Wnt signalling meets epigenetics.Stem Cell Investig. 2016 Aug 12;3:38. doi: 10.21037/sci.2016.08.01. eCollection 2016. Stem Cell Investig. 2016. PMID: 27668245 Free PMC article. No abstract available.
-
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers.Cancers (Basel). 2016 Jul 14;8(7):66. doi: 10.3390/cancers8070066. Cancers (Basel). 2016. PMID: 27429001 Free PMC article. Review.
References
-
- Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT, Bryder D, Yang L, Borge OJ, Thoren LA, et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell. 2005;121:295–306. - PubMed
-
- Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J. Cell Sci. 2007;120:3327–3335. - PubMed
-
- Austin TW, Solar GP, Ziegler FC, Liem L, Matthews W. A role for the Wnt gene family in hematopoiesis: Expansion of multilineage progenitor cells. Blood. 1997;89:3624–3635. - PubMed
-
- Baba Y, Yokota T, Spits H, Garrett KP, Hayashi S, Kincade PW. Constitutively active beta-catenin promotes expansion of multipotent hematopoietic progenitors in culture. J. Immunol. 2006;177:2294–2303. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI058162-04/AI/NIAID NIH HHS/United States
- R01 AI058162-03/AI/NIAID NIH HHS/United States
- R01 AI058162-05/AI/NIAID NIH HHS/United States
- R01 AI058162-02/AI/NIAID NIH HHS/United States
- AI058162/AI/NIAID NIH HHS/United States
- R01 AI020069-24/AI/NIAID NIH HHS/United States
- R21 AI069024/AI/NIAID NIH HHS/United States
- R01 AI020069-23/AI/NIAID NIH HHS/United States
- R01 AI020069-25A2/AI/NIAID NIH HHS/United States
- R21 AI069024-01A1/AI/NIAID NIH HHS/United States
- AI069024/AI/NIAID NIH HHS/United States
- R01 AI058162/AI/NIAID NIH HHS/United States
- AI02069/AI/NIAID NIH HHS/United States
- R01 AI020069/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources